Preclinical Data Shows Benefits of AMT-101 for Ulcerative Colitis
Earlier this month, biopharmaceutical company Applied Molecular Transport (AMT) announced the publication of its preclinical data in the Journal of Immunology. You can find the published article here. Within the study,…